Articles/Reports

[WSJ] Will Gilead’s Hepatitis C Drug Bust State Budgets?

Jul 17, 2014

Will the cost of new hepatitis C treatments bust state budgets? A new analysis Read More

[The Washington Post] How do you pay for a drug that costs $84,000?

Jul 15, 2014

“As longtime health-care advocate John Rother sees it, the Sovaldi issue is Read More

[The Hill] Poll: 4 in 5 say $1,000-a-pill drug cost ‘unacceptable’

Jul 15, 2014

Eighty-two percent in a new poll say the cost of a $1,000-a-pill medicine Read More

[The Hill] Wyden, Grassley question hep C drug’s high cost

Jul 11, 2014

Two high-ranking senators have lent their voices to the chorus demanding to Read More

[Politico] Wyden, Grassley want answers on Sovaldi

Jul 11, 2014

By: Brett Norman A bipartisan pair of senators is asking the pharmaceutical Read More

[Bloomberg News] U.S. Senators Ask Gilead to Explain $84,000 Hep C Drug Pricing

Jul 11, 2014

Gilead Sciences Inc. has been asked by two U.S. senators to explain how it Read More

[NCHC] AEI Session on Financing Cures: White Hat or White Wash?

Jul 10, 2014

On Friday, July 11, AEI is hosting a session entitled “How will we pay for Read More

[The Health Care Blog] The Coming Debate Over Specialty Drugs

Jul 2, 2014

The debate over the price of specialty drugs is intensifying and could well be Read More

[NCHC] New York Joins List of States Outraged Over Sovaldi

Jun 30, 2014

Costs to New Yorkers for One Drug Is 4 Times Entire Higher Education Spending Read More

[Forbes.com] Bitter Pill To Swallow: Can The US Market Bear The Cost Of Sovaldi?

Jun 28, 2014

Sovaldi, the new drug to treat and cure Hepatitis C has certainly caused quite Read More

[Forbes.com] The Sovaldi Tax: Gilead Can’t Justify The Price It’s Asking For Hepatitis C Therapy

Jun 18, 2014

A cure for hepatitis C is within reach for 170 million people around the world Read More

[The Oregonian] Oregon Health Plan Balk at Hepatitis C Drug Coverage

Jun 16, 2014

Eyeing a $168-million annual price tag for two costly new hepatitis C drugs, Read More